Primary Birmingham Hip Resurfacing Arthroplasty Using a Metal-on-Metal Couple in the Young Active Patient

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00285948
First received: February 1, 2006
Last updated: February 17, 2009
Last verified: February 2009
  Purpose

To prospectively obtain data about the clinical and radiological results of the resurfacing technique as primary hip prosthesis in young active patients


Condition Intervention
Indications for a Total Hip Prosthesis
Device: Primary Birmingham hip resurfacing arthroplasty using a metal-on-metal couple

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Primary Birmingham Hip Resurfacing Arthroplasty Using a Metal-on-Metal Couple in the Young Active Patient

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Clinical and radiological results

Estimated Enrollment: 250
Study Start Date: November 1998
Study Completion Date: January 2009
Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Total hip prosthesis

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00285948

Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Rene Verdonk, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

Responsible Party: René Verdonk, University Hospital Ghent
ClinicalTrials.gov Identifier: NCT00285948     History of Changes
Other Study ID Numbers: 2004/339
Study First Received: February 1, 2006
Last Updated: February 17, 2009
Health Authority: Belgium: Institutional Review Board

ClinicalTrials.gov processed this record on April 17, 2014